NCT04465643 2025-10-08
Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)